New insider activity at Pfizer ( (PFE) ) has taken place on March 7, 2025.
Senior Vice President and Controller Jennifer B. Damico has recently sold 3,249 shares of Pfizer stock, amounting to a total transaction value of $84,373.
Recent Updates on PFE stock
Pfizer has recently made several strategic moves and announcements impacting its stock. The company appointed James List as Chief Internal Medicine Officer, which is expected to bolster its internal medicine portfolio. Additionally, Pfizer is considering shifting overseas manufacturing to its U.S. plants in response to potential tariffs, highlighting its operational flexibility. The company also commented on its rebate expenses, indicating higher rebates in the first half of the year and lower in the latter half. Despite these developments, Bernstein lowered Pfizer’s price target due to a cautious outlook on the realization of Pfizer’s R&D strategy and the need for evidence of its effectiveness by 2025. This reflects a wait-and-see approach regarding Pfizer’s long-term strategic outcomes.
More about Pfizer
YTD Price Performance: -0.61%
Average Trading Volume: 40,438,910
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $145.9B